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ABSTRACT
White spot syndrome virus (WSSV) is the causative agent
of a disease that has led to severe mortalities of cultured
shrimp in Taiwan and many other countries. WSSV, a kind of
large enveloped DNA virus, has a wide host range among
crustaceans. During the first stage to infect a target cell, the
enveloped virus must combine itself with the receptor on the
host cell membrane via an envelope protein. In WSSV,
binding of envelope protein with the receptor of the host
cell membrane was revealed in a number of previous studies.
WSSV envelope proteins were also considered to form a
protein complex, at some stage in all research to be named
“infectome”. The WSSV envelope protein VP41A, with the
predicted molecular weight of about 41 kDa and having a
transmembrane region at its C-terminus, is identified in this
study. The interaction of VP41A with the virus’ major envelope protein VP26 is revealed by His pull-down and liquid
chromatography tandem mass spectrometry. Furthermore,
the protein-protein interaction of VP41A with VP28 and VP56
is verified by far western blotting. This data indicate that
VP41A participates in the formation of a WSSV protein
complex that may be involved in WSSV infection. These
findings may identify certain areas for further WSSV research.

I. INTRODUCTION
White spot syndrome virus (WSSV) is one of the most
serious pathogens which cause viral infection in the shrimp
culture industry throughout the world. This virus has a broad
host range of most of the crustaceans. WSSV, the only
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member of the genus Whispovirus, now divided into a new
family Nimaviridae, is a large enveloped, ellipsoid, and double-stranded DNA virus [6, 8, 13, 18, 20]. Although considerable progress has been made in determining the WSSV
genomics and structural proteins, the early stages of the
morphogenesis with regard to the process of the virus infecting the host cell is only recently being revealed.
WSSV is an enveloped DNA virus. Up until now, there are
at least 58 structural proteins identified. In addition, over 30
proteins were classified as envelope proteins within the structural proteins [15, 16, 22, 24]. Viral envelope proteins play a
crucial role in viral infection. There are many studies about
the interaction of WSSV envelope proteins and the host cell,
such as the study that determined that PmCBP interacts with
11 structural proteins (VP24, VP31, VP32, VP39B, VP53A,
VP56, VP41A, VP53B, VP51B, VP110 and VP124); the study
that determined that VP28 interacts with PmRab7 and the
study that determined that VP187 binds with the β-integrin
[4, 5, 9, 14]. Moreover, several studies have identified interaction between envelope proteins themselves, for example the
study that determined that WSV010 interacts with VP24, the
study that determined VP19 interacts with VP51A, the study
that determined VP24 interacts with VP28 and VP38A, the
study that determined VP26 interacts with VP19, VP24, VP28
and VP51A, the study that determined that VP37 interacts
with VP26 and VP28 [1-3, 7, 12, 17, 23]. With more protein
interactions gradually being revealed, research attention shifted
from the interaction between pairs of proteins, to the interaction between multiprotein complexes [2, 4, 25]. The “infectome” concept was proposed after the interaction between
nine structural proteins was identified [2].
In addition, a total of 11 envelope proteins have been identified to interact with PmCBP, one of host membrane protein
was thought to act as receptor of WSSV entry into the host
cell [4]. Apart from VP24 and VP31, there has been far less
research on the identification of those envelope proteins, or on
their interactions [3, 7, 10, 11]. In this study, VP41A, one of
11 viral envelope proteins which has been identified to interact strongly with PmCBP, was selected to determine its
interaction with other WSSV proteins. Identification of
VP41A was mainly performed by western blotting and IEM,

P.-Y. Huang et al.: Identification of WSSV Envelope Protein VP41A

235

Table 1. Sequences of the primers used in this study.
Gene

Primer

VP41A-F
VP41A-N-His
VP41A-N-His-R
VP24-F
VP24
VP24-R
VP28-F
VP28
VP28-R
VP31-F
VP31
VP31-R
VP32-F
VP32
VP32-R
VP39B-F
VP39B
VP39B-R
VP53A-F
VP53A
VP53A-R
VP56-F
VP56
VP56-R
CBP-F
PmCBP
CBP-R
The sequence of the restriction site is underlined.*

and investigation of the interaction of VP41A and those viral
envelope proteins was performed by His pull-down assay and
far-western blotting. The data shows that VP41A can interact
with VP26, VP28 and VP56, but not with VP24, VP31, VP32,
VP39B and VP53A. We believe that identifying the interaction between VP41A and other envelope proteins will provide
us with a means to elucidate the role of VP41A in the WSSV
structure and perhaps even the initial manner in which WSV
infects a host cell.

II. MATERIALS AND METHODS
1. Virus Purification
WSSV, referred to as the WSSV Taiwan-1 strain (WSSV
T-1 strain), was collected in 1994 in Taiwan from infected
Penaeus monodon [18]. The hemolymph was collected from
experimentally WSSV-infected shrimps (Penaeus vannamei;
mean weight: 15 g), diluted 1:4 with phosphate-buffered
saline, and frozen at -80°C. From this virus stock, a sample
(0.5 ml) was centrifuged (1,500 × g for 10 min), and the supernatant was filtered (0.45-µm filter) and injected (0.1 ml;
1:100 dilution in phosphate-buffered saline) intramuscularly
into healthy 20 g crayfish (Procambarus clarkia) between the
second and third abdominal segments. Between 5 and 7 days
after injection, 2 infected crayfish were collected each day for
investigation. All tissues excluding hepatopancreas were
homogenized for 2 min using a mechanical homogenizer (IKA
T-25) in 200 ml TNE buffer (50 mM Tris-HCl, 500 mM NaCl,
5 mM EDTA, pH 8.5) containing protease inhibitors (1 mM
phenylmethylsulfonyl fluoride) on ice and then centrifuged

Primer sequence 5’ → 3’
5’-GACAAGCTTATGTTGTTTGATTTCTTTCTAAAA-3’
5’- TGGCTCGAGCTACTCATCACC-3
5’- CGGGATCCGACCAACATAGAACTTAAC-3’
5’-GAGAGAATTCTTTTTCCCCAACCTTAAAC-3’
5’-CGGGGATCCATGGATCTTTCTTTCACTCT-3’
5’-CTCGAATTCTTACTCGGTCTCAGTGCCAG-3’
5’-CGGGATCCGATGTCTAATGGC-3’
5’-CTCGAATTCTTACTCCTCCTT-3’
5’-CCGAATTCGATGTCTTTGTTT-3’
5’-GCGAAGCTTTCAACGGAGCAT-3’
5’-CGGGATCCGATGTCGTCTAAC-3’
5’-GCAAGCTTCAGCTAAAAAAC-3’
5’-GGGGATCCGATAACGGTTGAAGGAGTC-3’
5’-GGAAGCTTTTACATCAACACTGTAACTGC-3’
5’-CGGGATCCGACAGACGTTTATAGAAGATGC-3’
5’-GCAAGCTTTTACACAATTTTC-3’
5’-TCCGAATTCGGGCAGTGGATTCACT-3’
5’-AGGTCGACTGGCTTAAATCTTTTCCTT-3’

at 6,000 × g for 5 min. The supernatant was filtered through a
nylon net (400 mesh) and centrifuged at 30,000 × g for 30 min.
After the supernatant was discarded, the upper loose layer
(pink) of the pellet was rinsed out carefully using a dropper,
and the lower compact gray layer was resuspended in 2 ml
TESP buffer (50 mM Tris-HCl, 5 mM EDTA, 500 mM NaCl,
pH 8.5). The crude virus suspensions were centrifuged at
6,000 × g for 5 min, and the supernatant was centrifuged again
at 30,000 × g for 30 min. After the supernatant and pink loose
layer were removed, the white pellet was resuspended in 0.2
ml TM buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.5) and
transferred to two 1.5 ml tubes. The suspension was centrifuged three times at 800 × g for 3 min each time, to remove
pink impurities [21]. Finally, the white pure virus suspension
was stored at 4°C until used (as described below in 5, 6 and 7).
The purity of the virus preparation was evaluated by negative-staining transmission electron microscopy (TEM).
2. Expression and purification of recombinant WSSV
envelope proteins (rVP41A, rVP24, rVP28, rVP31,
rVP32, rVP39B, rVP53A and rVP56), rPmCBP and
Maltose binding protein (rMBP) in Escherichia coli
The WSSV envelope protein genes were amplified from
the genomic DNA of WSSV T-1 strain with the primers listed
in Table 1. The recombinant plasmids were transformed into
E. coli BL21 (DE3) and cultures were induced with 1mM
IPTG and harvested. Recombinant PmCBP (rPmCBP) was
also generated by pET28b+ system. The resultant recombinant plasmid, pET28-PmCBP-C was transformed into E. coli
BL21 (DE3) strain. E. coli BL21 (DE3) cells were cultured
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in LB medium with 25 µg/ml kanamycin and the protein
was induced with 1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG). The recombinant proteins, tagged with 6 consecutive
histidines were purified by QIAexpressionist™ nickelnitrilotriacetic acid (Ni-NTA) metal-affinity chromatography
(Qiagen) according to the manufacturer’s recommendations.
The resultant resins were washed with buffer (pH 8.0) containing 50 mM sodium phosphate, 0.3 M sodium chloride
and 10 mM imidazole and eluted with the buffer (pH 8.0)
containing 50 mM sodium phosphate, 0.3 M sodium chloride
and 250 mM imidazole. The eluted protein was then concentrated using Amicon Ultra-15 centrifugal filters (Millipore) in
PBS buffer and stored at 4°C for further antiserum production. The details of generating recombinant PmCBP and recombinant maltose binding protein (rMBP) and polyclonal
rabbit anti-PmCBP antibody were described in a previous
study [4, 19].

New Zealand white rabbits were used to develop polyclonal
antiserum for each recombinant protein. In brief, New Zealand white rabbits were hyperimmunized by injection with
250 µg proteins emulsified in complete Freund’s adjuvant.
Subsequent booster injections were carried out with 250 µg
protein emulsified in incomplete Freund’s adjuvant. The antiserum was collected after the antibody titer had peaked.

6. Localization of VP41A by Immunoelelctron Microscopy
(IEM)
A purified WSSV virion suspension was adsorbed to
Formvar-supported and carbon-coated nickel grids (150 mesh)
and incubated for 5 min at room temperature. The grids were
floated on drops of blocking buffer (5% bovine serum albumin,
5% normal goat serum, 0.1% cold water fish skin gelatin, 10
mM phosphate buffer, 150 mM NaCl, pH 7.4) at room temperature for 30 min to reduce nonspecific binding, and then
washed with incubation buffer (0.1% AURION BSA-CTM,
15 mM NaN3, 10 mM phosphate buffer, 150 mM NaCl, pH
7.4) for 5 min. Grids were incubated with anti-VP41A rabbit
polyclonal antibody diluted 1:50 (by volume) in incubation
buffer for 1 h at room temperature. After the grids had been
washed three times with drops of incubation buffer, they were
incubated with the secondary antibody (goat anti-rabbit conjugated to 15 nm gold particles, EMS), then diluted 1:50 in the
incubation buffer for 1h at room temperature. Control staining
to demonstrate immunohistochemical specificity included
replacement of primary antibody by preimmune rabbit serum
for 1 h at room temperature. The grids were washed extensively with incubation buffer and phosphate buffer. Finally the
grids were washed with distilled water five times to remove
excess salt. After drying, the grids were stained with 1.5%
PTA pH 7.2 for 30 s. Specimens were examined by transmission electron microscopy (TEM).

4. Western Blot Analysis

7. His Pull-Down Assay

For Western blot analysis, proteins that had been separated
in SDS-PAGE were transferred onto a polyvinylidene difluoride (PVDF) membrane (Micron Separations) by semi-dry
blotting. Membranes were blocked in 5% skim milk (Difco
Laboratories) in TBS (0.2 M NaCl and 50 mM Tris-HCl, pH
7.4). Immunodetection was performed by incubation of the
blot in each polyclonal rabbit anti-recombinant protein serum
diluted 1:5000 in TBS with 5% skim milk for 1 h at room temperature. Subsequently, anti-rabbit IgG antibody conjugated
with horseradish peroxidase (Sigma) was used at a concentration of 1:5000 and detection was performed with a Western
Blot Chemiluminescence Reagent (NEN Life Sciences).

A modified His pull-down assay was used to test the interaction between VP41A and other WSSV proteins. The
purified His-tagged VP41A (rVP41A-N-His) was bound to 20
µl Ni-nitriloacetic acid (Ni-NTA) beads (Bioman) in PBS for 1
hr with gentle rotation, mixing sample with the beads. Beads
were washed three times for 10 min each in PBS containing
0.1% Triton X-100, and once in binding buffer (20 mM
HEPES, 100 mM NaCl, 0.5 mM EDTA, 0.1% Triton X-100,
10% glycerol). The beads were incubated in 200 µl binding
buffer with either of envelope or nucleocapsid, then, washed 3
times with the binding buffer to remove nonspecific binding.
Bound proteins were eluted in 20 µl 2 × SDS sample buffer,
and analyzed by SDS-PAGE and mass spectrometry analysis.

3. Anti-VP41A Antiserum Production

5. Separating the Envelope and Tegument of Purified
Virions
The method to separate WSSV envelope, tegument and
nucleocapsid portions was described in the report published by
Tsai et al. [16]. The purified virions (5 µg of total protein)
were incubated in 3 different solutions for 30 min at room
temperature: 100 µl TM buffer, 100 µl TM buffer with trypsin
(5 µg/ml; Promega), 100 µl of TM buffer with trypsin (5 µg/ml)
and 1% Triton X-100. The virions were added at 1/50th
volume of protease inhibitors (Roche) and then treated at
37°C for 1 h. In some samples, Triton X-100 was added to the
concentration of 1% to remove the viral envelope and expose
the internal structure. The sample separated by SDS-PAGE,
transferred to a PVDF membrane for western blotting.

8. Protein Identification by Liquid
Chromatography-Mass Spectrometry (LC/MS)
Protein bands of the His pull-down assay were manually
excised from the SDS-PAGE gel. Identification of the sample
proteins by LC/MS/MS was manipulated by Mission Biotech
Co., Ltd. The analyses of the peptide sequences and their
alignment were through the NCBI database (http://www.ncbi.
nlm.nih.gov/).
9. Far-Western Blot Assay
The target viral envelope proteins were separated by SDSPAGE, transferred to a PVDF membrane and renatured gradually at 4°C overnight in HEPES buffer (20 mM HEPES, 100
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Fig. 1. A. Schematic diagram of the WSSV envelope protein; the recombinant region of VP41A protein in this study is shown in the gray
box. B. Recombinant protein expression in E. coli and purification of rVP41A-N-His. Lanes M, pre-stained molecular weight
marker; lane 1: non-induced; lane 2: induced; lane 3: purified
rVP41A-N-His fusion protein.

mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween
20, 10% glycerol, pH 7.5) containing 5% non-fat milk. The
blot was washed and incubated with 40 µg binding protein
(rVP41A-N-His) in 10 ml incubation buffer (20 mM Tris/HCl,
150 mM NaCl, 0.05% Tween 20, 3% non-fat milk, pH 7.5) for
2 h at room temperature. Then the blot was incubated in a
polyclonal rabbit antibody of each binding protein diluted
1:5000 in TBST with 5% skim milk for 1 h at room temperature. Subsequently, goat anti-rabbit IgG antibody conjugated
with horseradish peroxidase (Jackson) was used at a concentration of 1:5000 and detection was performed with a Western
Lightning™ Plus-ECL (Bioman).

III. RESULTS
1. Production and Purification of VP41A Recombinant
Protein
Initially, we attempted to express full-length VP41A in E.
coli. However, it could not be expressed under experimental
conditions. Thus, the N-terminal fragment of VP41A was
cloned into the pET28b vector and expressed as a His fusion
protein (VP41A-N-His) in the BL21 (DE3) strain. The
rVP41A-N-His protein expressed in the induction sample was
analyzed by SDS-PAGE (15% gels). A band approximately 22
kDa was observed (Fig. 1A). The expressed rVP41A-N-His
fusion protein was purified by Ni-NTA affinity chromatography. The purified protein was used to immunize rabbit and
anti-VP41A antiserum was collected for further study.
2. Analysis of VP41A Localization on WSSV
To confirm the VP41A localization and to test the specificity of anti-VP41A antiserum, western blotting analysis was
performed by using the whole virions, envelope and nucleocapsid fractions. As shown in Fig. 2, western blot analysis

Fig. 2. A. Coomassie brilliant blue-stained 12% SDS-PAGE of the
structural proteins of WSSV. B. Western blot analysis of WSSV
virions and the envelope and nucleocapsid fractions with VP41A
pre-immune serum. C. Western blot analysis of WSSV virions
and the envelope and nucleocapsid fractions with VP41A antiserum. Lane M: Marker; 1, purified WSSV virions; 2. WSSV nucleocapsid; 3. WSSV envelope; 4. Purified rVP41A-N-His. Arrow:
VP41A on WSSV. Arrow head: rVP41A-N-His protein.

A

B
anti-VP41A

Trypsin
Triton X-100
kDa 55
43
34
26

− +
− −

+
+
kDa

C
anti-VP28

anti-VP26

− +
− −

− +
− −

+
+

+
+

kDa

34

34

26

26

17

17

Fig. 3. Western blot analysis showing trypsin- or/and Triton X-100treated virions recognized by anti-VP28, anti-VP26 and antiVP41A antisera.

indicated that the anti-VP41A signal only showed up in WSSV
virions and in the envelope fraction (Fig. 2C, lane 1 and 3);
opposite the pre-immune serum shows some non-specific
signal but the pre-immune serum can not recognized VP41A
or VP41A-N-His.
To further confirm the VP41A localization, the purified virions were treated with trypsin and/or Triton X-100. Trypsin
is used to removing the WSSV envelope; however, Triton
X-100 is stronger than trypsin and it is used here to remove the
WSSV envelope and the inner tegument [16]. VP28 and VP26
were selected as contrasts for they were revealed as envelope
and tegument proteins, respectively. As shown in Fig. 3A, the
positive signal did appear in the virions sample treated with
neither trypsin nor Triton X-100. Those results showed that
the VP41A protein is present exclusively in the WSSV envelope as VP28.
3. Observation of the Localization of VP41A by
Immunoelectron Microscopy (IEM)
More evidence presents the localization of VP41A by IEM.
The results showed that the gold particles could be revealed
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Table 2. Peptide sequences detected by LC/MS/MS.

Fig. 4. Localization of VP41A by IEM. A. Intact virions incubated with
anti-VP41A antiserum as primary antibody, followed by goldlabeled secondary antibodies. Gold particles are indicated by
arrows. B. Nucleocapsids incubated with anti-VP41A serum,
followed by gold-labeled secondary antibodies. C. Intact virions
incubated with normal rabbit serum, followed by gold-labeled
secondary antibodies. Scale bar: 100 nm.

A
kDa

B
1

2

1

2

70
55

Start-End
41-51
68-75
89-103
104-119
166-174
175-192
193-202

Mr (calc)
1344.5802
878.4498
1542.8253
1605.7342
1047.5634
1950.8669
1185.6605

Observed
673.30
440.22
772.42
803.88
524.79
976.44
593.84

Sequence
SVVANYDQMMR
SYNTPLGK
DVSALVISTVTAPR
TDPAGTGAENSNMTLK
ITLIDVCSK
FEDGAAFEATMNIGFTSK
NVIDIKDEIK

were found to bind with rVP41A-N-His (Fig. 5A, lane 1).
Analysis of this 20 kDa protein by mass spectrometry showed
that this protein is compatible with the NCBI database and
similar to VP26 (Table 2). The western blot analysis showed
that anti-VP26 antibody reacted at the same band (Fig. 5B,
lane 2), indicating that the VP26 can associate with the VP41A
N-terminus.
5. Identification of WSSV Protein Interacting with
VP41A by Far-Western Blot Assay

40
35
25
VP26
15

Fig. 5. His pull-down of WSSV by rVP41A-N-His. A. SDS-PAGE of
eluted proteins. B. Western blot analysis by anti-VP26 antiserum.
Lane 1: the nu cleocapsid fraction incubated with the His-beads
coupling with rVP41A-N-His. Lane 2: the envelope fraction incubated with the His-beads coupling with rVP41A-N-His.

on intact WSSV virions when using the anti-VP41A serum as
the primary antibody (Fig. 4A), but was not found when the
envelope was removed (Fig. 4B). No gold particles were found
on the WSSV virions when using normal rabbit serum as
primary antibody (Fig. 4C). These data indicate that VP41A is
an envelope protein of WSSV.
4. Identification WSSV Protein interacting with
VP41A by His Pull-Down Assay
To identify which protein of WSSV can interact with
VP41A, His pull-down assay was performed in this study.
Before we started this procedure of His pull-down assay,
WSSV virions were separated to envelope proteins and nucleocapsid proteins and bound with rVP41A-N-His, separately.
The SDS-PAGE revealed an obvious band with molecular
masses of approximately 20 kDa in the envelope fraction
(Fig. 5A, lane 2). Another band at an upper position of this
20 kDa band was rVP41A-N-His. No nucleocapsid proteins

Recently, protein-protein interaction can be verified by many
techniques such as yeast-two hybrid (Y-2-H) screening, virus
overlay protein binding assay (VOPBA), phage display, farwestern blotting and other immunological methods (pull down
assay, co-immunoprecipitation). In this study, far-western
blotting was selected to identify the protein-protein interaction
between VP41A and other WSSV proteins. In the previous
study, VP41A could bind to PmCBP with another 10 envelope
proteins [4]. Since PmCBP can interact with multiple WSSV
envelope proteins, to understand the interaction between these
envelope proteins becomes particularly important. Hence,
further work is required to investigate the interaction between
VP41A and other envelope proteins. Due to the fact that several proteins failed to be produced in prokaryotic or eukaryotic
protein production systems, only seven envelope proteins
(VP24, VP28, VP31, VP32, VP39B, VP53A and VP56) are
selected to verify their interaction with VP41A (VP41A Nterminus). Far-western blot assay results showed that VP41A
N-terminus can associate with VP28 and VP56. PmCBP was
set as the positive control for the interaction between PmCBP,
and VP41A was already identified (Fig. 6). We notice that
in the lane of the VP28 sample, the anti-VP41A antibody
revealed multiple bands. This may be because VP28 tends
to become the protein dimer, and some recombination VP28
proteins degrade during protein purification (i.e. they break
down into smaller proteins). The same phenomenon also
occurs in recombinant PmCBP sample. Oppositely, the VP41A
N-terminus did not interact with VP24, VP31, VP32, VP39B
and VP53A. The rMBP as the protein negative control.

IV. DISCUSSION
Until now, over 30 envelope proteins of WSSV have been
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Fig. 6. Determining the interaction between VP41A and WSSV envelope
proteins. A. The Coomassie-blue stained SDS-PAGE gel. B. Farwestern blotting. Proteins on PVDF membrane were hybridized
with rVP41A-N-His and then recognized by anti-VP41A antiserum. C. Far-western blotting. Proteins on PVDF membrane
were hybridized with rMBP and then recognized by anti-VP41A
antiserum.

recognized [16]. In recent years, several studies have noted
that WSSV envelope proteins bind themselves to the host cell
receptor, such as VP41A and other ten proteins with PmCBP,
VP28 with PmRab7, and VP187 with β-integrin [4, 9, 14]. In
addition, with more information about the interaction between
proteins identified, several studies have noted that WSSV
envelope proteins might form protein complexes. Zhou et al.
first noted that VP28, VP24, VP19 and VP26 could form a
protein complex [25]. Chang et al. later provided the concept
of a so-named “infectome”, formed by nine proteins WSV010,
VP19, VP24, VP26, VP28, VP37, VP38A, VP51A, and VP51C
[2].
In this here study, we found that the VP41A protein was
present only in the viral envelope fraction and located on the
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WSSV virion surface as identified by western blotting and
IEM. Those findings reveal that the VP41A is an envelope
protein of WSSV. In subsequent experiments, we performed a
His-pull down assay to determine whether VP41A can interact
with other envelope proteins. In this part of our experiments, a
clear signal was observed at the position of approximately 20
kDa, and this protein was identified as VP26 by LC/MS/MS
and western blotting using anti-VP26 antiserum. Moreover,
VP41A and other envelope proteins have been shown to interact with PmCBP [1].
We also tried to study the interaction between VP41A and
some other ten envelope proteins; unfortunately, several
proteins failed to be produced in prokaryotic or eukaryotic
protein production systems, so only seven proteins were
selected to verify or deny the interaction by far-western blot
analysis. The far-western blot showed that the VP41A
N-terminus can interact with VP28 and VP56, but not with
VP24, VP31, VP32, VP39B and VP53A. Noteworthy is that
VP28 would not interact with PmCBP [4], but VP41A can
interact with PmCBP and VP28. It was speculated that
VP41A might be the “linker” between PmCBP and VP28.
Besides, VP28 and VP26 are known to be the two most
abundant structural proteins on the viral envelope and
tegument. Thus, VP41A may associate with VP28 and VP26
and make the structure more stable. It should be noted that
the protein-protein interaction results we show in this study
were performed by using VP41A N-terminus, due to the
failure to produce the full-length VP41A. Although the
VP41A N-terminus is predicted to be exposed outside the
virus, other proteins are still able to interact with VP41A at
the inner part of the virion.
It is important to emphasize that methodological problems
in the design of this research limit our interpretations. One of
the thorniest problems researchers face is that studies are
needed to elucidate the combination of proteins in the actual
virus (not to mention its interactions with the proteins of the
host cell). Relatively close to the interaction of actual virion is
the virus overlay protein binding assay (VOPBA) and pull
down assay, but these still have the misfolding problem when
using the expressed protein as the binding protein. And the
amount of the virion envelope proteins may lead to some
envelope proteins to be rarely observed. Other in vitro binding
assay like: yeast-two hybrid (Y-2-H) screening, far-western
blotting and co-immunoprecipitation (co-IP), might solve the
problem of the amount of protein, but it is still hard to explicitly determine the interactive relationship of the actual virion.
Despite these disadvantages, the in vitro binding assay still
gave us some direction to elucidate the interaction between the
abovementioned envelope proteins.
So far, there has been only very limited functional characterization of WSSV envelope proteins. The discovery of the
interaction between VP41A/VP26, VP41A/VP56, VP41A/
VP28 and VP41A/PmCBP could help us to better understand
the actual WSSV infection process. However, more studies
are needed on the interaction between these two protein com-
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plexes. Furthermore, such interaction may provide potential
target areas for the design of anti-WSSV drugs.

13.

ACKNOWLEDGMENTS
This investigation was supported financially by the National Science Council Grants (NSC 100-2321-B-019-007MY3). We appreciate Mr. Vince J. Genis and Miss Angela
Wang for their positive commentaries on the manuscript.

14.

15.

REFERENCES
1. Chang, Y. S., Liu, W. J., Chou, T. L., Lee, Y. T., and Lee, T. L., “Characterization of white spot syndrome virus envelope protein VP51A and its
interaction with viral tegument protein VP26,” Journal of Virology, Vol.
82, No. 22, pp. 12555-12564 (2008).
2. Chang, Y. S., Liu, W. J., Lee, C. C., Chou, T. L., Lee, Y. T., Wu, T. S.,
Huang, J. Y., Huang, W. T., Lee, T. L., Kou, G. H., Wang, A. H. J., and
Lo, C. F., “A 3D model of the membrane protein complex formed by the
white spot syndrome virus structural proteins,” PloS One, Vol. 5, No. 5,
e10718 (2010).
3. Chen, J., Li, Z., and Hew, C. L., “Characterization of a novel envelope
protein WSV010 of shrimp white spot syndrome virus and its interaction
with a major viral structural protein VP24,” Virology, Vol. 364, No. 1, pp.
208-213 (2007).
4. Chen, K. Y., Hsu, T. C., Huang, P. Y., Kang, S. T., Lo, C. F., Huang, W. P.,
and Chen, L. L., “Penaeus monodon chitin-binding protein (PmCBP) is
involved in white spot syndrome virus (WSSV) infection,” Fish and
Shellfish Immunology, Vol. 27, No. 3, pp. 460-465 (2009).
5. Chen, L. L., Lu, L. C., Wu, W. J., Lo, C. F., and Huang, W. P., “White spot
syndrome virus envelope protein VP53A interacts with Penaeus monodon
chitin-binding protein (PmCBP),” Diseases of Aquatic Organisms, Vol.
74, No. 3, pp. 171-178 (2007).
6. Escobedo-Bonilla, C. M., Alday-Sanz, V., Wille, M., Sorgeloos, P., Pensaert,
M. B., and Nauwynck, H. J., “A review on the morphology, molecular
characterization, morphogenesis and pathogenesis of white spot syndrome virus,” Journal of Fish Diseases, Vol. 31, No. 1, pp. 1-18 (2008).
7. Jie, Z., Xu, L., and Yang, F., “The C-terminal region of envelope protein
VP38 from white spot syndrome virus is indispensable for interaction
with VP24,” Archives of Virology, Vol. 153, No. 11, pp. 2103-2106 (2008).
8. Leu, J. H., Yang, F., Zhang, X., Xu, X., Kou, G. H., and Lo, C. F.,
“Whispovirus,” Current Topics in Microbiology and Immunology, Vol.
328, pp. 197-227 (2009).
9. Li, D. F., Zhang, M. C., Yang, H. J., Zhu, Y. B., and X, Xu., “β-integrin
mediates WSSV infection,” Virology, Vol. 368, No. 1, pp. 122-132 (2007).
10. Li, L., Lin, Z., Xu, L., and Yang, F., “The RGD motif in VP31 of white
spot syndrome virus is involved in cell adhesion,” Archives of Virology,
Vol. 156, No. 8, pp. 1317-1321 (2011).
11. Li, L., Xie, X., and Yang, F., “Identification and characterization of a
prawn white spot syndrome virus gene that encodes an envelope protein
VP31,” Virology, Vol. 340, No. 1, pp. 125-132 (2005).
12. Liu, Q. H., Ma, C. Y., Chen, W. B., Zhang, X. L., and Liang, Y., “White

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

spot syndrome virus VP37 interacts with VP28 and VP26,” Diseases of
Aquatic Organisms, Vol. 85, No. 1, pp. 23-30 (2009).
Lo, C. F., Leu, J. H., Ho, C. H., Chen, C. H., Peng, S. E., Chen, Y. T.,
Chou, C. M., Yeh, P. Y., Huang, C. J., Chou, H. Y., Wang, C. H., and Kou,
G. H., “Detection of baculovirus associated with white spot syndrome
(WSBV) in penaeid shrimps using polymerase chain reaction,” Diseases
of Aquatic Organisms, Vol. 25, pp. 133-141 (1996).
Sritunyalucksana, K., Wannapapho, W., Lo, C. F., and Flegel, T. W.,
“PmRab7 is a VP28-binding protein involved in white spot syndrome
virus infection in shrimp,” Journal of Virology, Vol. 80, No. 21, pp. 1073410742 (2006).
Tsai, J. M., Wang, H. C., Leu, J. H., Hsiao, H. H., Wang, A. H. J., Kou, G. H.,
and Lo, C. F., “Genomic and proteomic analysis of thirty-nine structural
proteins of shrimp white spot syndrome virus,” Journal of Virology, Vol.
78, No. 20, pp. 11360-11370 (2004).
Tsai, J. M., Wang, H. C., Leu, J. H., Wang, A. H. J., and Zhuang, Y.,
“Identification of the nucleocapsid, tegument, and envelope proteins of
the shrimp white spot syndrome virus virion,” Journal of Virology, Vol.
80, No. 6, pp. 3021-3029 (2006).
Wan, Q., Xu, L., and Yang, F., “VP26 of white spot syndrome virus
functions as a linker protein between the envelope and nucleocapsid of
virions by binding with VP51,” Journal of Virology, Vol. 82, No. 24, pp.
12598-12601 (2008).
Wang, C. H., Lo, C. F., Leu, J. H., Chou, C. M., Yeh, P. Y., Chou, H. Y.,
Tung, M. C., Chang, C. F., Su, M. S., and Kou, G. H., “Purification and
genomic analysis of baculovirus associated with white spot syndrome
(WSBV) of Penaeus monodon,” Diseases of Aquatic Organisms, Vol. 23,
pp. 239-242 (1995).
Witteveldt, J., Vlak, J. M., and van Hulten, M. C. W., “Protection of
Penaeus monodon against white spot syndrome virus using a WSSV
subunit vaccine,’’ Fish and Shellfish Immunology, Vol. 16, No. 5, pp. 571579 (2004).
Wongteerasupaya, C., Vickers, J. E., Sriurairatana, S., Nash, G. L.,
Akarajamorn, A., Boonsaeng, V., Panyim, S., Tassankajon, A., Withyanchumnarnkul, B., and Flegel, T. W., “A non-occluded, systemic baculovirus that occurs in cells of ectodermal and mesodermal origin and
causes high mortality in black tiger prawn Penaeus monodon,” Diseases
of Aquatic Organisms, Vol. 21, No. 1, pp. 69-77 (1995).
Xie, X., Li, H., Xu, L., and Yang, F., “A simple and efficient method for
purification of intact white spot syndrome virus (WSSV) viral particles,’’
Virus Res., Vol. 108, pp. 63-67 (2005).
Xie, X., Xu, L., and Yang, F., “Proteomic analysis of the major envelope
and nucleocapsid proteins of white spot syndrome virus,” Journal of Virology, Vol. 80, No. 21, pp. 10615-10623 (2006).
Xie, X. and Yang, F., “White spot syndrome virus VP24 interacts with
VP28 and is involved in virus infection,” The Journal of General Virology, Vol. 87, No. 7, pp. 1903-1908 (2006).
Zhang, X., Huang, C., Tang, X., Zhuang, Y., and Hew, C. L., “Identification of structural proteins from shrimp white spot syndrome virus
(WSSV) by 2DE-MS,” Proteins, Vol. 55, No. 2, pp. 229-235 (2004).
Zhou, Q., Xu, L., Li, H., Qi, Y. P., and Yang, F., “Four major envelope
proteins of white spot syndrome virus bind to form a complex,” Journal
of Virology, Vol. 83, No. 9, pp. 4709-4712 (2009).

